CERS: Cerus Company Total Sales

cerus.com - graphic logo of issuer CERS

Regulatory barriers provide Cerus Corporation (CERS) with high margins and protection from competitors. The company's sales timeline demonstrates current operational efficiency, where 0.23 forms the current metric indicator. Revenue growth relies on the implementation of the INTERCEPT system into new blood components and FDA approval. Patent protection and its status as a medical safety standard completely eliminate the risk of price dumping.

Cerus Corp (CERS) - Company Sales from 07/04/2022 to 11/18/2026

Comprehensive metric breakdowns and analytics for cerus.com (CERS)

- market value and analyst target forecast:
- market capitalization information:
Comprehensive company analysis:Cerus CERS
Signature product of Cerus Corporation

This indicator aggregates the total volume of goods and services sold during the reporting period. The metric assesses cash flow resilience amid inflationary pressure and high interest rates. For Cerus Corporation (CERS), revenue is generated through the mandatory use of consumables within the pathogen inactivation system. The absence of B2B customer churn guarantees revenue stability. By analyzing the company's gross sales level, an investor can objectively evaluate the pace of business scaling.

Competing companies

Intuitive (ISRG) - Company Gross Revenue|Company Revenue Danaher (DHR)|BDX (Becton, Dickinson and Company) - Company Sales Revenue|STERIS PLC - Company Sales|Revenue and Sales Volume West Pharma Corp WST|BAX - Company Revenue|MASI - Revenue and Sales Volume|Stevanato Group SpA (STVN) - Company Revenue|Company Total Revenue Teleflex Inc. (TFX)|MMSI (merit.com) - Revenue and Sales Volume|Company Total Revenue Nobel Biocare NVST|Company Revenue ICU Medical (ICUI)|Dentsply Sirona - Company Sales Volume|LeMaitre Vascular, Inc. - Company Sales|Company Total Sales ATRC (AtriCure Inc)|STAA - Company Revenue|Company Gross Revenue ChromaDex Corp NAGE|ZIMV (ZimVie Dental) - Company Sales|angiodynamics.com (ANGO) - Revenue and Sales Volume|Company Revenue Teknova|Company Total Revenue Monogram Technologies Inc. MGRM|Revenue and Sales Volume STSS|INFU: Company Annual Revenue|Revenue and Sales Volume UTMD (Utah Medical Products)|Revenue and Sales Volume korumedical.com KRMD|nyxoah.com - Revenue and Sales Volume|Company Total Revenue Microbot Medical|PDEX: Revenue and Sales Volume|Zentek Ltd. (ZTEK) - Revenue and Sales Volume|Company Sales ELUT|Company Total Revenue milestonescientific.com MLSS|Revenue and Sales Volume NXGL|Company Revenue RVP (Retractable Technologies Inc.)|Revenue and Sales Volume HBIO (Harvard Bioscience)|Company Gross Revenue Femasys Corporation (FEMY)|MHUA - Company Revenue|Company Total Revenue Predictive Oncology Inc|CJMB (Callan JMB Corp) - Company Sales|Company Annual Revenue ATRI (Atrion Corp.)|Company Sales NURO